• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by LMF Acquisition Opportunities Inc. (Amendment)

    8/10/23 1:29:40 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials
    Get the next $LMAO alert in real time by email
    SC 13G/A 1 cohenco-icu073123a2.htm



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*



    SeaStar Medical Holding Corporation

    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    81256L104

    (CUSIP Number)

     

     

    July 31, 2023
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    o Rule 13d-1(b)

    x Rule 13d-1(c)

    o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

    CUSIP No.  81256L104
     SCHEDULE 13G/A
    Page 2 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Vellar Opportunities Fund Master, Ltd.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Cayman Islands
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,001,000**
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,001,000**
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,001,000**
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.5%
    12
    TYPE OF REPORTING PERSON
     
    CO

    **The SPV entity is Vellar Opportunity Fund SPV LLC – Series 4 which is wholly owned by Vellar Opportunities Fund Master, Ltd.

     



     

    CUSIP No.  81256L104
     SCHEDULE 13G/A
    Page 3 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Cohen & Company LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,001,000**
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,001,000**
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,001,000**
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.5%
    12
    TYPE OF REPORTING PERSON
     
    OO, HC

    **The SPV entity is Vellar Opportunity Fund SPV LLC – Series 4 which is wholly owned by Vellar Opportunities Fund Master, Ltd.

     

     


     

    CUSIP No.  81256L104
     SCHEDULE 13G/A
    Page 4 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Cohen & Company Inc.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,001,000**
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,001,000**
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,001,000**
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.5%
    12
    TYPE OF REPORTING PERSON
     
    CO, HC

    **The SPV entity is Vellar Opportunity Fund SPV LLC – Series 4 which is wholly owned by Vellar Opportunities Fund Master, Ltd.

     

     


     

    CUSIP No.  81256L104
     SCHEDULE 13G/A
    Page 5 of 11 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Daniel Cohen
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,001,000**
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,001,000**
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,001,000**
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.5%
    12
    TYPE OF REPORTING PERSON
     
    IN, HC

    **The SPV entity is Vellar Opportunity Fund SPV LLC – Series 4 which is wholly owned by Vellar Opportunities Fund Master, Ltd.

     

      


     

     

    CUSIP No. 81256L104
     SCHEDULE 13G/A
    Page 6 of 11 Pages

     

    Item 1.(a) Name of Issuer

    SeaStar Medical Holding Corporation

    Item 1.(b) Address of Issuer’s Principal Executive Offices

    3513 Brighton Blvd, Suite 410

    Denver, CO 80216

    Item 2.(a) Name of Persons Filing:

    Vellar Opportunities Fund Master, Ltd.

    Cohen & Company LLC

    Cohen & Company Inc.

    Daniel Cohen

      

    Item 2.(b) Names of Person Filing, Address of Principal Business Office, Citizenship:

    Vellar Opportunities Fund Offshore, Ltd.

    c/o Mourant Governance Services (Cayman) Limited 94

    Solaris Avenue, Camana Bay

    PO Box 1348 Grand Cayman KY1-1108

    Cayman Islands

     

    Cohen & Company LLC

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

     

    Cohen & Company Inc.

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

     

    Daniel Cohen

    c/o Cohen & Company Inc.

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

      

    Item 2.(c) Citizenship:

     Vellar Opportunities Fund Master, Ltd. – Cayman Islands

    Cohen & Company LLC – Delaware, United States

    Cohen & Company Inc. – Delaware, United States

    Daniel Cohen – United States

      

    Item 2.(d) Title of Class of Securities

    Common Stock, par value $0.0001 per share (the “Common Stock”)

     

    Item 2.(e) CUSIP No.:

    81256L104

     

    CUSIP No.  81256L104
     SCHEDULE 13G/A
    Page 7 of 11 Pages

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
      (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
      (k) ¨ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                            
           

     

    CUSIP No. 81256L104
     SCHEDULE 13G/A
    Page 8 of 11 Pages

     

     

    Item 4. Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    Vellar Opportunities Fund Master, Ltd.

    (a) Amount beneficially owned: 1,001,000

    (b) Percent of class: 5.5%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,001,000

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,001,000

     

    Cohen & Company, LLC

    (a) Amount beneficially owned: 1,001,000

    (b) Percent of class: 5.5%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,001,000

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,001,000

     

    Cohen & Company Inc.

    (a) Amount beneficially owned: 1,001,000

    (b) Percent of class: 5.5%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,001,000

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,001,000

     

    Daniel Cohen:

    (a) Amount beneficially owned: 1,001,000

    (b) Percent of class: 5.5%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,001,000

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,001,000

     

    Item 5. Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

    Not Applicable.

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Please see Exhibit II attached hereto.

    Item 8. Identification and Classification of Members of the Group

    Not Applicable.

    Item 9. Notice of Dissolution of Group 

    Not Applicable.

    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     
    CUSIP No. 81256L104
     SCHEDULE 13G/A
    Page 9 of 11 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: August 10, 2023

     

     

     

     

    Vellar Opportunities Fund Master, Ltd.

           
      By:  /s/ Solomon I. Cohen
        Solomon I. Cohen, Director
           
     

    Cohen & Company LLC

           
      By:  /s/ Joseph Pooler
        Joseph Pooler, Chief Financial Officer
           
     

    Cohen & Company Inc.

           
      By:  /s/ Daniel Cohen
        Daniel Cohen, Chairman of the Board of Directors
           
     

           
      By:  /s/ Daniel Cohen
       
           
           

     

     
    CUSIP No. 81256L104
     SCHEDULE 13G/A
    Page 10 of 11 Pages

     

    Exhibit I

     

    JOINT FILING STATEMENT

     

    PURSUANT TO RULE 13d-1(k)

     

    The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint Acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Dated: August 10, 2023

     

     

    Vellar Opportunities Fund Master, Ltd.

           
      By:  /s/ Solomon I. Cohen
        Solomon I. Cohen, Director
           
     

    Cohen & Company LLC

           
      By:  /s/ Joseph Pooler
        Joseph Pooler, Chief Financial Officer
           
     

    Cohen & Company Inc.

           
      By:  /s/ Daniel Cohen
        Daniel Cohen, Chairman of the Board of Directors
           
     

           
      By:  /s/ Daniel Cohen
     
     
     
    CUSIP No. 81256L104
     SCHEDULE 13G/A
    Page 11 of 11 Pages

     

    Exhibit II

     

    Vellar Opportunities Fund Master, Ltd., Cohen & Company LLC and Cohen & Company Inc. are the relevant entities for which Mr. Cohen may be considered a control person.

    Get the next $LMAO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMAO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LMAO
    SEC Filings

    View All

    LMF Acquisition Opportunities Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement

    8-K - SeaStar Medical Holding Corp (0001831868) (Filer)

    2/16/24 8:00:10 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form EFFECT filed by LMF Acquisition Opportunities Inc.

    EFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)

    2/15/24 12:15:35 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form S-8 filed by LMF Acquisition Opportunities Inc.

    S-8 - SeaStar Medical Holding Corp (0001831868) (Filer)

    2/9/24 4:20:19 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Van Heel Kenneth bought $40,000 worth of shares (100,000 units at $0.40), increasing direct ownership by 610% to 116,400 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    11/27/23 4:05:14 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts

    – Company advancing clinically proven platform therapy, the Selective Cytopheretic Device (SCD), to address the life-threatening consequences of hyperinflammation – SCD lead program in Acute Kidney Injury (AKI) with potential FDA approval for pediatric AKI targeted for Q1 2023 and commencement of pivotal trial in adult AKI targeted in Q1 2023 – Ongoing exploratory clinical research to refine patient populations where SCD may be effective to fuel pipeline with potential in high-value hyperinflammatory indications– SeaStar Medical commenced trading on Nasdaq under the ticker "ICU" today, Monday, October 31st Denver, Colorado, Oct. 31, 2022 (GLOBE NEWSWIRE) -- SeaStar Med

    10/31/22 9:25:47 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities

    LMF Acquisition Opportunities Renamed SeaStar Medical Holding Corporation SeaStar Medical Holding Corporation Common Stock and Warrants to Commence Trading on Nasdaq Under New Ticker Symbol "ICU" and "ICUCW" DENVER and TAMPA, Fla., Oct. 28, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, Inc., a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced that it has completed its previously announced business combination with LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company sponsored by LM Funding America, Inc. (NASDAQ:LMFA). The business combination closed on October

    10/28/22 1:20:32 PM ET
    $LMAO
    $LMFA
    Consumer Electronics/Appliances
    Industrials
    Finance: Consumer Services
    Finance

    LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.

    DENVER and TAMPA, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company sponsored by LM Funding America, Inc. (NASDAQ:LMFA), and SeaStar Medical, Inc., a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced that LMAO stockholders voted to approve the previously proposed business combination with SeaStar Medical at LMAO's special meeting of LMAO stockholders (the "Special Meeting") held earlier today, October 18, 2022. More than 96% of the votes cast at the meeting voted to approve the business combination with SeaStar Med

    10/18/22 6:00:00 PM ET
    $LMAO
    $LMFA
    Consumer Electronics/Appliances
    Industrials
    Finance: Consumer Services
    Finance

    $LMAO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Green David A

    3 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    1/22/24 9:11:04 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    Schlorff Eric was granted 60,248 shares, increasing direct ownership by 8% to 837,823 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    11/29/23 4:15:25 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    Chung Kevin was granted 63,422 shares, increasing direct ownership by 43% to 210,860 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    11/29/23 4:15:01 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by LMF Acquisition Opportunities Inc. (Amendment)

    SC 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)

    2/14/24 9:50:57 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by LMF Acquisition Opportunities Inc. (Amendment)

    SC 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)

    8/10/23 1:29:40 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by LMF Acquisition Opportunities Inc. (Amendment)

    SC 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)

    2/14/23 3:38:15 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Financials

    Live finance-specific insights

    View All

    LM Funding Reports Net Income of $11.1 Million or $2.05 Per Basic Common Share for the Second Quarter of 2021

    TAMPA, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ:LMFA) ("LM Funding" or "LMFA"), a technology-based specialty finance company, today announced its financial results for the three and six months ended June 30, 2021. Financial Highlights for the Three and Six Month Period Ended June 30, 2021: Net income attributable to LM Funding for the three and six-month periods ended June 30, 2021 totaled $11.1 million or $2.05 per basic and diluted share and $15.5 million or $2.96 per basic and $2.95 per diluted share, respectively.Cash increased to $22.2 million or approximately $4.09 per basic and diluted share on June 30, 2021 as compared to $11.6 million

    8/16/21 4:10:00 PM ET
    $LMAO
    $LMFA
    Consumer Electronics/Appliances
    Industrials
    Finance: Consumer Services
    Finance

    $LMAO
    Leadership Updates

    Live Leadership Updates

    View All

    SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development

    Denver, Colo. and Tampa, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company, today announced the appointment of Dr. Sai Prasad N. Iyer, Ph.D to the position of Vice President, Medical Affairs and Clinical Development at SeaStar Medical, effective September 15, 2022. Dr. Iyer brings 20 years of industry experience and will provide leadership in developing and executing clinical trials, including SeaStar Medical's upcoming pivotal clinical trial of its Sel

    9/19/22 8:30:00 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer

    DENVER, CO and TAMPA, FL, May 24, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Inc., a medical technology company developing a platform therapy to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company, today announced that Kevin Chung, MD will join SeaStar Medical as Chief Medical Officer (CMO), effective July 1, 2022. Dr. Chung brings over 20 years of experience as an accomplished critical care physician with expertise in extracorporeal life support therapies (ECLS). Since his fellowship training in critical care at Walter Reed Army Medical Center, Dr. Chung has treated thousands o

    5/24/22 8:00:00 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials